Tandem discounts transition to new insulin pump platform
HomeHome > News > Tandem discounts transition to new insulin pump platform

Tandem discounts transition to new insulin pump platform

Mar 24, 2024

August 3, 2023 By Sean Whooley

The San Diego-based company’s program provides new and renewing, eligible users of its insulin pump a pathway to its new offerings. Users of the t:slim X2 insulin pump in the U.S. can use the program to move toward owning a Tandem Mobi system for $199.

The FDA cleared the Mobi automated insulin delivery (AID) system earlier this month. Tandem Diabetes Care expects to begin a limited launch later this year, with general availability slated for early 2024.

Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Health Technology, Patient Monitoring, Software / IT Tagged With: Tandem Diabetes Care

Get the full story at our sister site, Drug Delivery Business News.